Versant Ventures and Novartis Launch Borealis Biosciences With $150 Million in Funding
–Founding investor Versant partners with Novartis to create biotech with potential to be a leading company in the field of RNA medicines for kidney disease– –Emerges from stealth with more than $150 million in combined…